Drug facts
BrandInfed (Iron Dextran)
No generic iron dextran is approved; no Infed patent or exclusivity is listed in the Orange Book.
Infed was first approved by the FDA before 1982 under NDA 017441; the application holder is Allergan Sales LLC.
The latest NADAC for INFED 100 MG/2 ML VIAL is $18.93 per mL (as of 10/28/2026).
Holder Allergan Sales LLCApplication NDA 017441Approved before 1982
01Patents and exclusivity
When competition can legally begin. A generic can launch once both exclusivity and the last listed patent expire, unless a court or settlement says otherwise.
- Latest patent
- No Infed patent listed in the Orange Book Orange Book
02Competition
- Generics
- No generic approved Orange Book
Every listingEach listing and maker behind the generics count.
Price erosionHow NADAC moves as generics enter.
PrescribersWho prescribes it, from Medicare data.
Available in the full Infed profile.See what is included
03Supply and price
- FDA drug shortage
- ClearNot on the current shortage list FDA shortages
- NADAC
- $18.93 per mLINFED 100 MG/2 ML VIAL, as of 10/28/2026 CMS NADAC
04Product
- Application holder
- Allergan Sales LLC Orange Book
- Application
- NDA 017441 Orange Book
- First approved
- before 1982 Orange Book
- Dosage forms
- injectable
- Routes
- injection
Sources: FDA Orange Book, FDA Purple Book, FDA drug shortages, FDA enforcement reports and CMS NADAC, read through QOPE. Not medical or legal advice.